GO:0036094 | small molecule binding | 26.42% (14/53) | 2.66 | 0.0 | 3e-06 |
GO:0003674 | molecular_function | 52.83% (28/53) | 1.51 | 0.0 | 5e-06 |
GO:0043168 | anion binding | 24.53% (13/53) | 2.57 | 0.0 | 8e-06 |
GO:0003824 | catalytic activity | 35.85% (19/53) | 1.95 | 0.0 | 9e-06 |
GO:0043167 | ion binding | 28.3% (15/53) | 2.31 | 0.0 | 1e-05 |
GO:0044281 | small molecule metabolic process | 15.09% (8/53) | 3.59 | 0.0 | 1.1e-05 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 13.21% (7/53) | 3.88 | 0.0 | 1.5e-05 |
GO:0006520 | cellular amino acid metabolic process | 11.32% (6/53) | 4.33 | 0.0 | 1.5e-05 |
GO:0016787 | hydrolase activity | 20.75% (11/53) | 2.69 | 1e-06 | 1.7e-05 |
GO:0000166 | nucleotide binding | 22.64% (12/53) | 2.52 | 1e-06 | 1.8e-05 |
GO:1901265 | nucleoside phosphate binding | 22.64% (12/53) | 2.52 | 1e-06 | 1.8e-05 |
GO:0097367 | carbohydrate derivative binding | 20.75% (11/53) | 2.58 | 2e-06 | 2.1e-05 |
GO:0005488 | binding | 35.85% (19/53) | 1.72 | 1e-06 | 2.1e-05 |
GO:0032555 | purine ribonucleotide binding | 20.75% (11/53) | 2.61 | 1e-06 | 2.1e-05 |
GO:0032553 | ribonucleotide binding | 20.75% (11/53) | 2.58 | 2e-06 | 2.1e-05 |
GO:0017076 | purine nucleotide binding | 20.75% (11/53) | 2.59 | 2e-06 | 2.1e-05 |
GO:0097159 | organic cyclic compound binding | 28.3% (15/53) | 2.07 | 1e-06 | 2.2e-05 |
GO:1901363 | heterocyclic compound binding | 28.3% (15/53) | 2.07 | 1e-06 | 2.2e-05 |
GO:0044238 | primary metabolic process | 28.3% (15/53) | 2.02 | 2e-06 | 2.4e-05 |
GO:0035639 | purine ribonucleoside triphosphate binding | 20.75% (11/53) | 2.62 | 1e-06 | 2.5e-05 |
GO:0043436 | oxoacid metabolic process | 11.32% (6/53) | 3.94 | 2e-06 | 2.6e-05 |
GO:0019752 | carboxylic acid metabolic process | 11.32% (6/53) | 3.94 | 2e-06 | 2.6e-05 |
GO:0006082 | organic acid metabolic process | 11.32% (6/53) | 3.93 | 3e-06 | 2.6e-05 |
GO:0008152 | metabolic process | 32.08% (17/53) | 1.78 | 3e-06 | 3.4e-05 |
GO:0071704 | organic substance metabolic process | 28.3% (15/53) | 1.93 | 5e-06 | 4.3e-05 |
GO:0017111 | nucleoside-triphosphatase activity | 11.32% (6/53) | 3.75 | 5e-06 | 4.8e-05 |
GO:1901564 | organonitrogen compound metabolic process | 20.75% (11/53) | 2.38 | 6e-06 | 5.2e-05 |
GO:0016462 | pyrophosphatase activity | 11.32% (6/53) | 3.69 | 7e-06 | 5.5e-05 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 11.32% (6/53) | 3.68 | 7e-06 | 5.6e-05 |
GO:0006807 | nitrogen compound metabolic process | 24.53% (13/53) | 2.05 | 9e-06 | 7.2e-05 |
GO:0009058 | biosynthetic process | 16.98% (9/53) | 2.66 | 1e-05 | 8e-05 |
GO:0044237 | cellular metabolic process | 24.53% (13/53) | 1.93 | 2.3e-05 | 0.000171 |
GO:0008144 | drug binding | 16.98% (9/53) | 2.49 | 2.7e-05 | 0.000193 |
GO:0019238 | cyclohydrolase activity | 3.77% (2/53) | 7.57 | 3.6e-05 | 0.000253 |
GO:1901576 | organic substance biosynthetic process | 15.09% (8/53) | 2.63 | 4e-05 | 0.000272 |
GO:0016887 | ATPase activity | 7.55% (4/53) | 4.35 | 4.4e-05 | 0.000286 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 3.77% (2/53) | 7.15 | 7.2e-05 | 0.000463 |
GO:1901566 | organonitrogen compound biosynthetic process | 11.32% (6/53) | 3.04 | 8.5e-05 | 0.000533 |
GO:0034641 | cellular nitrogen compound metabolic process | 16.98% (9/53) | 2.25 | 9.4e-05 | 0.00057 |
GO:0008150 | biological_process | 33.96% (18/53) | 1.35 | 9.8e-05 | 0.000579 |
GO:0004386 | helicase activity | 5.66% (3/53) | 5.04 | 0.0001 | 0.000581 |
GO:0005524 | ATP binding | 15.09% (8/53) | 2.42 | 0.000112 | 0.00063 |
GO:0030554 | adenyl nucleotide binding | 15.09% (8/53) | 2.41 | 0.000117 | 0.000631 |
GO:0032559 | adenyl ribonucleotide binding | 15.09% (8/53) | 2.41 | 0.000115 | 0.000636 |
GO:0044249 | cellular biosynthetic process | 13.21% (7/53) | 2.49 | 0.000228 | 0.001203 |
GO:1901605 | alpha-amino acid metabolic process | 5.66% (3/53) | 4.53 | 0.000292 | 0.001505 |
GO:0009987 | cellular process | 26.42% (14/53) | 1.46 | 0.000363 | 0.00183 |
GO:0016741 | transferase activity, transferring one-carbon groups | 5.66% (3/53) | 3.98 | 0.000894 | 0.004415 |
GO:0044283 | small molecule biosynthetic process | 5.66% (3/53) | 3.91 | 0.001047 | 0.005064 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 9.43% (5/53) | 2.46 | 0.0021 | 0.009956 |
GO:0004375 | glycine dehydrogenase (decarboxylating) activity | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0016642 | oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0042135 | neurotransmitter catabolic process | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0009071 | serine family amino acid catabolic process | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0004399 | histidinol dehydrogenase activity | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0042133 | neurotransmitter metabolic process | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0004635 | phosphoribosyl-AMP cyclohydrolase activity | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0006546 | glycine catabolic process | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:1901606 | alpha-amino acid catabolic process | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0006544 | glycine metabolic process | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0001505 | regulation of neurotransmitter levels | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0004358 | glutamate N-acetyltransferase activity | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0003941 | L-serine ammonia-lyase activity | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0004827 | proline-tRNA ligase activity | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0006433 | prolyl-tRNA aminoacylation | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0016841 | ammonia-lyase activity | 1.89% (1/53) | 8.15 | 0.003512 | 0.010811 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 3.77% (2/53) | 4.76 | 0.002435 | 0.011317 |
GO:0019001 | guanyl nucleotide binding | 5.66% (3/53) | 3.23 | 0.003997 | 0.012146 |
GO:0032561 | guanyl ribonucleotide binding | 5.66% (3/53) | 3.35 | 0.00319 | 0.012599 |
GO:0001882 | nucleoside binding | 5.66% (3/53) | 3.35 | 0.00319 | 0.012599 |
GO:0032550 | purine ribonucleoside binding | 5.66% (3/53) | 3.35 | 0.00319 | 0.012599 |
GO:0032549 | ribonucleoside binding | 5.66% (3/53) | 3.35 | 0.00319 | 0.012599 |
GO:0005525 | GTP binding | 5.66% (3/53) | 3.35 | 0.00319 | 0.012599 |
GO:0001883 | purine nucleoside binding | 5.66% (3/53) | 3.35 | 0.00319 | 0.012599 |
GO:1901360 | organic cyclic compound metabolic process | 11.32% (6/53) | 2.03 | 0.00333 | 0.012938 |
GO:0034645 | cellular macromolecule biosynthetic process | 7.55% (4/53) | 2.59 | 0.004326 | 0.012978 |
GO:0046483 | heterocycle metabolic process | 11.32% (6/53) | 2.08 | 0.002849 | 0.012984 |
GO:0006725 | cellular aromatic compound metabolic process | 11.32% (6/53) | 2.06 | 0.002991 | 0.013375 |
GO:0043170 | macromolecule metabolic process | 15.09% (8/53) | 1.59 | 0.004659 | 0.013802 |
GO:1901607 | alpha-amino acid biosynthetic process | 3.77% (2/53) | 4.57 | 0.003179 | 0.013954 |
GO:0008652 | cellular amino acid biosynthetic process | 3.77% (2/53) | 4.25 | 0.004944 | 0.014289 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.77% (2/53) | 4.25 | 0.004944 | 0.014289 |
GO:0005737 | cytoplasm | 3.77% (2/53) | 4.15 | 0.005612 | 0.016025 |
GO:0016070 | RNA metabolic process | 7.55% (4/53) | 2.45 | 0.006164 | 0.01739 |
GO:0006412 | translation | 5.66% (3/53) | 2.93 | 0.007122 | 0.017956 |
GO:0004812 | aminoacyl-tRNA ligase activity | 3.77% (2/53) | 3.98 | 0.007065 | 0.018003 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 3.77% (2/53) | 3.98 | 0.007065 | 0.018003 |
GO:0003937 | IMP cyclohydrolase activity | 1.89% (1/53) | 7.15 | 0.007012 | 0.018263 |
GO:0009063 | cellular amino acid catabolic process | 1.89% (1/53) | 7.15 | 0.007012 | 0.018263 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 1.89% (1/53) | 7.15 | 0.007012 | 0.018263 |
GO:0004643 | phosphoribosylaminoimidazolecarboxamide formyltransferase activity | 1.89% (1/53) | 7.15 | 0.007012 | 0.018263 |
GO:0043039 | tRNA aminoacylation | 3.77% (2/53) | 4.02 | 0.006687 | 0.018428 |
GO:0043038 | amino acid activation | 3.77% (2/53) | 4.02 | 0.006687 | 0.018428 |
GO:0009059 | macromolecule biosynthetic process | 7.55% (4/53) | 2.4 | 0.006913 | 0.018832 |
GO:0043043 | peptide biosynthetic process | 5.66% (3/53) | 2.89 | 0.007658 | 0.019106 |
GO:0016053 | organic acid biosynthetic process | 3.77% (2/53) | 3.91 | 0.007848 | 0.019175 |
GO:0046394 | carboxylic acid biosynthetic process | 3.77% (2/53) | 3.91 | 0.007848 | 0.019175 |
GO:0006518 | peptide metabolic process | 5.66% (3/53) | 2.84 | 0.00841 | 0.020339 |
GO:0006139 | nucleobase-containing compound metabolic process | 9.43% (5/53) | 1.95 | 0.009236 | 0.022111 |
GO:0043604 | amide biosynthetic process | 5.66% (3/53) | 2.77 | 0.009617 | 0.022792 |
GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0019319 | hexose biosynthetic process | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0046364 | monosaccharide biosynthetic process | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0042737 | drug catabolic process | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0006525 | arginine metabolic process | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0006094 | gluconeogenesis | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0006526 | arginine biosynthetic process | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0016743 | carboxyl- or carbamoyltransferase activity | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0016597 | amino acid binding | 1.89% (1/53) | 6.57 | 0.0105 | 0.022831 |
GO:0043603 | cellular amide metabolic process | 5.66% (3/53) | 2.66 | 0.011843 | 0.025516 |
GO:0004784 | superoxide dismutase activity | 1.89% (1/53) | 6.15 | 0.013977 | 0.027604 |
GO:0016721 | oxidoreductase activity, acting on superoxide radicals as acceptor | 1.89% (1/53) | 6.15 | 0.013977 | 0.027604 |
GO:0016840 | carbon-nitrogen lyase activity | 1.89% (1/53) | 6.15 | 0.013977 | 0.027604 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 1.89% (1/53) | 6.15 | 0.013977 | 0.027604 |
GO:0031406 | carboxylic acid binding | 1.89% (1/53) | 6.15 | 0.013977 | 0.027604 |
GO:0005666 | RNA polymerase III complex | 1.89% (1/53) | 6.15 | 0.013977 | 0.027604 |
GO:0043177 | organic acid binding | 1.89% (1/53) | 6.15 | 0.013977 | 0.027604 |
GO:0000428 | DNA-directed RNA polymerase complex | 1.89% (1/53) | 6.15 | 0.013977 | 0.027604 |
GO:0019438 | aromatic compound biosynthetic process | 5.66% (3/53) | 2.56 | 0.014342 | 0.028091 |
GO:0018130 | heterocycle biosynthetic process | 5.66% (3/53) | 2.59 | 0.013563 | 0.028959 |
GO:0140101 | catalytic activity, acting on a tRNA | 3.77% (2/53) | 3.48 | 0.013826 | 0.029257 |
GO:0006383 | transcription by RNA polymerase III | 1.89% (1/53) | 5.83 | 0.017441 | 0.031796 |
GO:0016742 | hydroxymethyl-, formyl- and related transferase activity | 1.89% (1/53) | 5.83 | 0.017441 | 0.031796 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 1.89% (1/53) | 5.83 | 0.017441 | 0.031796 |
GO:0006006 | glucose metabolic process | 1.89% (1/53) | 5.83 | 0.017441 | 0.031796 |
GO:0009064 | glutamine family amino acid metabolic process | 1.89% (1/53) | 5.83 | 0.017441 | 0.031796 |
GO:0009084 | glutamine family amino acid biosynthetic process | 1.89% (1/53) | 5.83 | 0.017441 | 0.031796 |
GO:0048037 | cofactor binding | 5.66% (3/53) | 2.48 | 0.016541 | 0.031871 |
GO:0003924 | GTPase activity | 3.77% (2/53) | 3.35 | 0.016515 | 0.032082 |
GO:1901362 | organic cyclic compound biosynthetic process | 5.66% (3/53) | 2.47 | 0.016828 | 0.032163 |
GO:0006399 | tRNA metabolic process | 3.77% (2/53) | 3.2 | 0.02001 | 0.036201 |
GO:0016054 | organic acid catabolic process | 1.89% (1/53) | 5.57 | 0.020893 | 0.03723 |
GO:0046395 | carboxylic acid catabolic process | 1.89% (1/53) | 5.57 | 0.020893 | 0.03723 |
GO:0009069 | serine family amino acid metabolic process | 1.89% (1/53) | 5.35 | 0.024333 | 0.0409 |
GO:0030880 | RNA polymerase complex | 1.89% (1/53) | 5.35 | 0.024333 | 0.0409 |
GO:0006547 | histidine metabolic process | 1.89% (1/53) | 5.35 | 0.024333 | 0.0409 |
GO:0004222 | metalloendopeptidase activity | 1.89% (1/53) | 5.35 | 0.024333 | 0.0409 |
GO:0052803 | imidazole-containing compound metabolic process | 1.89% (1/53) | 5.35 | 0.024333 | 0.0409 |
GO:0000105 | histidine biosynthetic process | 1.89% (1/53) | 5.35 | 0.024333 | 0.0409 |
GO:0003676 | nucleic acid binding | 9.43% (5/53) | 1.6 | 0.023975 | 0.042404 |
GO:0090304 | nucleic acid metabolic process | 7.55% (4/53) | 1.86 | 0.024239 | 0.042553 |
GO:0016874 | ligase activity | 3.77% (2/53) | 2.92 | 0.028529 | 0.047615 |
GO:0034660 | ncRNA metabolic process | 3.77% (2/53) | 2.91 | 0.029235 | 0.048452 |